
A former Caltrans manager accepted more than $800,000 in bribes to award construction contracts to pre-selected companies at inflated prices, according to a US Attorney’s Office news release.
Choon Foo “Keith” Yong pleaded guilty to bribery and bid-rigging on Monday and agreed to cooperate with prosecutors in an ongoing investigation of the scheme, which involved at least two contractors and another employee, according to court documents and a news release from the US Attorney’s Office for the Eastern District of California.
As a contract manager in Caltrans’ Division of Procurement and Contracts, Yong “corruptly influenced” bidding in contracts worth more than $8 million from 2015 to 2019, steering most contracts to one unnamed contractor, according to documents filed with Yong’s plea agreement.
Yong was an employee at Caltrans from 1990 until his retirement in 2019, with the investigation into the rigging allegations starting after he left the company.
Yong was responsible for compiling lists of eligible bidders for projects to acquire, repair or improve Caltrans facilities, according to the plea agreement.
Another employee introduced him to the contractor, telling Yong he could make money by rigging the bids, according to the court documents. Yong manipulated the process by giving at least two contractors advance notice of upcoming bid opportunities, and then directed one or more of them to submit “sham bids,” making sure they were lower than bids from the contractor he had pre-selected.
The investigation into Yong’s bid rigging activities was carried out by the Procurement Collusion Strike Force at the DOJ, created in 2019. The Unit’s role has grown rapidly since its creation following expansions to infrastructure spending last year.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas